<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang JH</submitter><funding>National Defense Medical Center</funding><funding>Cheng Hsin General Hospital</funding><funding>Ministry of Science and Technology, Taiwan, ROC</funding><funding>Taoyuan Armed Forces General Hospital</funding><pagination>300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6683452</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>A chronic inflammatory state is a prominent feature in patients with end-stage renal disease (ESRD). Nuclear factor-kappa B (NF-κB) is a transcription factor that regulates the expression of genes involved in inflammation. Some genetic studies have demonstrated that the NF-κB genetic mutation could cause kidney injury and kidney disease progression. However, the association of a gene polymorphism in the transcription factor binding site of NF-κB with kidney disease is not clear.&lt;h4>Methods&lt;/h4>We used the Taiwan Biobank database, the University of California, Santa Cruz, reference genome, and a chromatin immunoprecipitation sequencing database to find single nucleotide polymorphisms (SNPs) at potential binding sites of NF-κB. In addition, we performed a case-control stud</pubmed_abstract><journal>BMC nephrology</journal><pubmed_title>Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease.</pubmed_title><pmcid>PMC6683452</pmcid><funding_grant_id>TAFGH-10429, TAFGH-10801</funding_grant_id><funding_grant_id>MAB-1050113, MAB-106-105, MAB-107-074, MAB-108-047</funding_grant_id><funding_grant_id>MOST107-2314-B016-052-MY3</funding_grant_id><funding_grant_id>CH-NDMC-105-5, CH-NDMC-106-4, CH-NDMC-107-13, CH-NDMC-108-6</funding_grant_id><pubmed_authors>Hsu YJ</pubmed_authors><pubmed_authors>Lee MC</pubmed_authors><pubmed_authors>Chin-Lin</pubmed_authors><pubmed_authors>Fang WH</pubmed_authors><pubmed_authors>Chen CF</pubmed_authors><pubmed_authors>Kuo CW</pubmed_authors><pubmed_authors>Su SL</pubmed_authors><pubmed_authors>Yang JH</pubmed_authors><pubmed_authors>Chen WT</pubmed_authors><pubmed_authors>Lin YH</pubmed_authors><pubmed_authors>Chang HL</pubmed_authors><pubmed_authors>Chen HC</pubmed_authors><pubmed_authors>Hsiao PJ</pubmed_authors><pubmed_authors>Tu MY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease.</name><description>&lt;h4>Background&lt;/h4>A chronic inflammatory state is a prominent feature in patients with end-stage renal disease (ESRD). Nuclear factor-kappa B (NF-κB) is a transcription factor that regulates the expression of genes involved in inflammation. Some genetic studies have demonstrated that the NF-κB genetic mutation could cause kidney injury and kidney disease progression. However, the association of a gene polymorphism in the transcription factor binding site of NF-κB with kidney disease is not clear.&lt;h4>Methods&lt;/h4>We used the Taiwan Biobank database, the University of California, Santa Cruz, reference genome, and a chromatin immunoprecipitation sequencing database to find single nucleotide polymorphisms (SNPs) at potential binding sites of NF-κB. In addition, we performed a case-control stud</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Aug</publication><modification>2026-05-01T04:42:05.566Z</modification><creation>2019-08-13T07:04:05Z</creation></dates><accession>S-EPMC6683452</accession><cross_references><pubmed>31382928</pubmed><doi>10.1186/s12882-019-1471-2</doi></cross_references></HashMap>